EQS-News: Marinomed focuses on growth after successful restructuring
EQS-News: Marinomed Biotech AG / Key word(s): Miscellaneous
Marinomed focuses on growth after successful restructuring
27.03.2025 / 07:45 CET/CEST
The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════
Marinomed focuses on growth after successful restructuring
• Marinomed plans to achieve an operating profit in 2025
• Budesolv: innovation for the treatment of allergic rhinitis
• Switzerland as a stepping stone for global!-->…